To read more on this topic click here.
Can a digital pen “revolutionise” Parkinson’s diagnosis?
Author: Sophie BatesPublished: 23 January 2020
Prep: Cook: Serves:
A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.
The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.
Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.
Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.
Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”
For more information on Parkinson’s and assessment tools please visit the Parkinson’s Europe website.
Share this story
Why you need more vitamin B3 in your diet
Discover the added value of vitamin B3 for Parkinson’s patientsREAD MORE
Parkinson’s in the news: December
A roundup of Parkinson’s news stories in DecemberREAD MORE
Could physical therapy be the future of specialised Parkinson’s care in Brazil?
Filling the physical therapy gaps in Brazil's healthcare systemREAD MORE